Luminal microvesicles uniquely influence translocating bacteria after SIV infection

Jacob K Flynn1, Charlotte A Langner1, Erik P Karmele2

  • 1Barrier Immunity Section, Laboratory of Viral Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.

Mucosal Immunology
|March 18, 2021
PubMed

Insights

HIV infection alters gut microvesicles, decreasing protective miRNAs and increasing antimicrobial peptides. This impacts bacterial growth, potentially driving inflammation and microbial translocation in HIV.

Area of Science:

  • Microbiology
  • Immunology
  • Virology

Background:

  • Microbial translocation, a key factor in HIV-associated inflammation, involves intestinal barrier dysfunction.
  • A bias exists towards the translocation of Proteobacteria, suggesting specific mechanisms at play.

Purpose of the Study:

  • To investigate if intestinal epithelial microvesicle cargo changes post-HIV infection and contributes to biased microbial translocation.
  • To identify specific molecular differences in microvesicles that influence bacterial growth.

Main Methods:

  • Isolation of gastrointestinal luminal microvesicles from rhesus macaques before and after simian immunodeficiency virus (SIV) infection.
  • Measurement of microvesicle miRNA and antimicrobial peptide content.
  • Co-culture experiments to assess the impact of microvesicles on commensal bacteria growth.

Main Results:

  • SIV infection led to decreased levels of specific miRNAs (miR-28-5p, -484, -584-3p, -584-5p, let-7b-3p) and increased beta-defensin 1 in microvesicles.
  • Isolated microvesicles from infected macaques showed dose-dependent inhibition of Lactobacillus salivarius growth.
  • These changes were not observed in non-progressively infected sooty mangabeys.

Conclusions:

  • Progressive SIV infection alters gut microvesicle composition, affecting antimicrobial control.
  • These alterations influence the growth of bacterial taxa that may translocate across the gut barrier.
  • Findings offer insights into novel therapeutic targets for HIV, microbial translocation, and chronic inflammation.